Home Feed Charts Wallet Profile

OIS Podcast | Ophthalmology's leading Podcast • Listen on Fountain

OIS Podcast | Ophthalmology's leading Podcast

OIS Podcast

Show • 425 episodes

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

Unlocking Breakthroughs in Ocular Surface TreatmentEpisode • Jul 11

Pharma, Devices & More: Inside the Future of GlaukosEpisode • Jun 6

Discover the Future of Non-Invasive Glaucoma CareEpisode • May 23

Transforming Myopia Treatment: Perry Sternberg Talks SYD-101Episode • May 9

Unlocking the Uveoscleral Pathway: Adam Szaronos on Bio-Interventional Innovation in GlaucomaEpisode • Apr 25

Bringing Presbyopia Back to the Forefront: Paul Smith of Orasis on The Rob & Jai Show, an Edition of the OIS PodcastEpisode • Apr 11

The View from the Street: Industry Trends, Strategic Shifts & Navigating UncertaintyEpisode • Mar 28

Breaking Barriers in Sustained Drug Delivery: Michael O’Rourke on The Rob & Jai Show edition of the OIS PodcastEpisode • Mar 14

Industry Titans Talk Ophthalmic Innovation: Andrew Stewart & Anthony Wallace on the Rob & Jai ShowEpisode • Feb 28

A Visionary Approach to Uveitis: Tarsier Pharma’s Disruptive InnovationEpisode • Feb 14

Next-Gen Innovators: Dr. Vikram Shankar on Advancing Patient Safety and Sustainability with DropmateEpisode • Jan 31

Insights from a Leader: Dave LeCause on Commercial Strategy and Innovation in Eye CareEpisode • Jan 17

The Power of Collaboration: From Early-Stage Innovation to Commercial StrategyEpisode • Jan 3

Redefining Ophthalmic Innovation: Stuart Therapeutics’ Journey Beyond Dry EyeEpisode • Dec 20, 2024

Company Quick TakesEpisode • Dec 6, 2024

Transforming Corneal CareEpisode • Nov 1, 2024

Revolutionizing Eye SurgeryEpisode • Oct 18, 2024

The Future of Vision TechnologyEpisode • Oct 4, 2024

Revolutionizing Corneal HealthEpisode • Aug 23, 2024

Venture Insights On Retinal InnovationEpisode • Aug 9, 2024

The View from the StreetEpisode • Jul 26, 2024

Celebrating 400 Episodes of OISEpisode • Jul 12, 2024

Advances in Corneal HealthEpisode • Jun 21, 2024

Revolutionizing Eye CareEpisode • Jun 7, 2024

Todays Therapies are Not Sufficient: A Marketplace Ripe for InnovationEpisode • May 24, 2024

AI and Robotics Transforming Retina MedicineEpisode • May 10, 2024

Exploring the FDAEpisode • Apr 26, 2024

Empathy in ActionEpisode • Apr 12, 2024

From Ophthalmology Clinics to Business LeadershipEpisode • Mar 29, 2024

Exploring the Future of Eye CareEpisode • Mar 15, 2024

5 Mistakes to Avoid in Biotech Investor Pitch DecksEpisode • Mar 1, 2024

Unlocking the Future of Presbyopia TreatmentEpisode • Feb 16, 2024

Revolutionizing Ophthalmic CareEpisode • Feb 2, 2024

Insights from Startup Leaders on Commercial Strategy and FundingEpisode • Jan 19, 2024

Maximizing the Value of Your Board of DirectorsEpisode • Jan 5, 2024

Quick Takes From Ophthalmology Start-UpsEpisode • Dec 22, 2023

Revolutionizing Retina Care Beyond InjectionsEpisode • Dec 15, 2023

Revolutionizing Glaucoma Treatment and Innovation InsightsEpisode • Dec 1, 2023

Ophthea's Transformative Shift, Clinical Successes, and Visionary InnovationEpisode • Nov 17, 2023

Building an Enterprise Under the RadarEpisode • Nov 3, 2023

Approachable Regenerative MedicineEpisode • Oct 20, 2023

The Bausch + Lomb Buzz, with Andrew Stewart and Yehia Hashad, MDEpisode • Oct 6, 2023

C-Suite Quick Takes: OIS Goes Behind the Scenes with Four Emerging Biotech CompaniesEpisode • Sep 22, 2023

CEO Quick TakesEpisode • Sep 8, 2023

The Latest on At-Home OCTEpisode • Aug 18, 2023

Accessing Charitable ResourcesEpisode • Aug 11, 2023

What’s New in Ocular Surface Disease?Episode • Aug 4, 2023

Accessing Capital and Navigating M&AsEpisode • Jul 28, 2023

When Is the Right Time to Form a Spin-Out? With Wesley Jackson, PhD, ValitorEpisode • Jul 21, 2023

Commercializing Demedex BlepharitisEpisode • Jul 14, 2023

From Lab Learning to Machine Learning, with Daniela Ferrara, GenentechEpisode • Jul 7, 2023

How Digital Innovation is Advancing OphthalmologyEpisode • Jun 30, 2023

Fueling the Innovation Engine, With Christoph Vonwiller, Johnson & Johnson VisionEpisode • Jun 23, 2023

Credibility, Cash, and Capability: The Benefits of Strategic Partnership, with Brian Culley, Lineage Cell TherapeuticsEpisode • Jun 16, 2023

A Fast, Fun Future, with Warren Foust and Magda Michna, PhD, Staar SurgicalEpisode • Jun 9, 2023

How Retina Physicians Can Use AI, With Natasa Jovic, RetinAIEpisode • May 19, 2023

The Inspiration Behind Syfovre, with Cedric FrancoisEpisode • May 5, 2023

Taking the Road Less Traveled, With Jod Mehta, Singapore National Eye CenterEpisode • Apr 28, 2023

The 3 Ingredients of a Successful Dry Eye Product, With Barry Linder, MD, Eyedetec MedicalEpisode • Apr 21, 2023

Meeting the Needs of Ophthalmic Surgeons, with Ed Timm, Mobius TherapeuticsEpisode • Apr 14, 2023

Pharma’s All or None, with Gianluca Rossetti, DompéEpisode • Apr 7, 2023

How Science Drives Decisions at Dompé, with Georgea PasedisEpisode • Mar 31, 2023

How Bausch + Lomb Identifies Product Gaps, With Anthony WallaceEpisode • Mar 22, 2023

Ocular Surface Disease SpotlightEpisode • Mar 10, 2023

Spotlight on MyopiaEpisode • Feb 24, 2023

Practicing and Advising on MedicineEpisode • Feb 17, 2023

Multimodal Myopia ManagementEpisode • Feb 10, 2023

Changing the Glaucoma Monitoring ParadigmEpisode • Feb 3, 2023

Metaverse MedicineEpisode • Jan 27, 2023

Perception, Vision, and GamingEpisode • Jan 20, 2023

New Possibilities for Corneal Disease TreatmentEpisode • Jan 13, 2023

Sit-downs with Eight OIS XII All-StarsEpisode • Dec 21, 2022

Expert Panel: How to Launch a ProductEpisode • Dec 14, 2022

Setting the Standards in ImagingEpisode • Nov 30, 2022

From Leading Global R&D Teams to Funding StartupsEpisode • Nov 23, 2022

The Potential of Entire-Eye OCT ImagingEpisode • Nov 16, 2022

Launching a Novel Dry Eye ProductEpisode • Nov 9, 2022

Meeting China’s Unmet NeedEpisode • Nov 2, 2022

The Game ChangerEpisode • Oct 26, 2022

Spotlight on OIS Israel at MIXiiiEpisode • Oct 19, 2022

Rayner’s Tim Clover on KOLs and IOLsEpisode • Oct 12, 2022

Glenn Tookey’s Mission Against BlindnessEpisode • Sep 28, 2022

Democratizing Cell TherapyEpisode • Sep 21, 2022

Santen’s Dr. Sallstig on People, Passion, and PerformanceEpisode • Sep 14, 2022

Great Minds Think DifferentlyEpisode • Aug 31, 2022

MedTech Ophthalmology European VC PanelEpisode • Aug 24, 2022

Flying Eye Hospitals and Machine Mentoring, with Orbis InternationalEpisode • Aug 17, 2022

Early-Stage Retina Drug Development FinancingEpisode • Aug 10, 2022

OIS Retina 2022: How to Execute New Treatments for Dry AMD and GAEpisode • Aug 3, 2022

Spotlight On Gene & Cell TherapyEpisode • Jul 27, 2022

Early-Stage Retina Drug Development FinancingEpisode • Jul 20, 2022

Ashley Brissette, MD: Academic and Eye-Focused Skincare EntrepreneurEpisode • Jun 22, 2022

Inside the Ocular Biofactory, with Thomas Chalberg, PhDEpisode • Jun 15, 2022

Creating Synergies Between Portfolio Companies, with Yaacov Michlin, BioLightEpisode • Jun 8, 2022

Dr. Raj Agrawal’s Dual MissionsEpisode • May 25, 2022

Roesky’s Quest: Durable Dry Eye TherapyEpisode • May 18, 2022

Seizing Opportunities with Novartis’ Dr. Jill HopkinsEpisode • May 11, 2022

Surfing Between Academic Medicine and Innovation with William Freeman, MDEpisode • May 4, 2022

Bilal Khan, New World Medical, on Balancing Mission with ProfitabilityEpisode • Apr 27, 2022

Success From Failure With Iveric Bio’s Dr. Pravin DugelEpisode • Apr 20, 2022

Treating ‘Lazy Eye’ with Screen TimeEpisode • Apr 13, 2022

Lessons Learned by AbbVie’s StewartEpisode • Apr 6, 2022

Tresserras’ Knack With Academic AssetsEpisode • Mar 30, 2022

Setting Innovation Guideposts, with Manoj Vyas & Sanjeev Ganatra, CBCC Global ResearchEpisode • Mar 9, 2022

From Enterprise CEO to VC Founder, with Richel LiuEpisode • Feb 23, 2022

Solving the Presbyopia Problem, with Robin SearsEpisode • Feb 16, 2022

Trying It All and Succeeding, With Adrienne GravesEpisode • Feb 9, 2022

A Laser-Focused Business Model, with Nir Katchinskiy, PhD and Lahav GilEpisode • Feb 2, 2022

The Coast to Coast Journey from Academic Research to Janssen Pharmaceuticals with Daniel Chao, MD, PhDEpisode • Jan 26, 2022

What’s New in Drug Delivery?Episode • Jan 19, 2022

Passionate Pursuits, With Brian Strem, Kiora PharmaceuticalsEpisode • Jan 12, 2022

Visionary Ventures, with Lori-Ann ChristieEpisode • Jan 5, 2022

Ophthalmology Innovation Year in ReviewEpisode • Dec 15, 2021

Treating the Untreatable Using Your Own Patient Experience, with Diana Driscoll, ODEpisode • Dec 8, 2021

Cracking the U.S. Dry Eye Market, With Brent Jones, CCO, I-MED PharmaEpisode • Nov 30, 2021

Moving From Medicine to Industry, With David Tanzer and Kerrie BradyEpisode • Nov 24, 2021

Faster, Better, Smarter, Cheaper, with Bill McPheeEpisode • Nov 17, 2021

Industry Insights on the Glaucoma Market from OIS Glaucoma Innovation ShowcaseEpisode • Nov 10, 2021

DIY Commercialization with Michael Gertner, MDEpisode • Nov 3, 2021

Change Creates Opportunity with Ramin ValianEpisode • Oct 27, 2021

Finding and Funding Assets in Retina, from OIS Retina@ASRSEpisode • Oct 20, 2021

The Next Cycle of Retinal Surgery Innovation, with Stanley Chang, MDEpisode • Oct 13, 2021

Solving the Dry Eye Mystery, With Jeffrey Krall, NeurolensEpisode • Oct 6, 2021

Following Intellectual Passions, With Dr. Baruch KuppermanEpisode • Sep 29, 2021

Revolutionizing Cataract Surgery from Innovation to CommercializationEpisode • Sep 22, 2021

From Big Pharma Lawyer to Eye Care Disruptor—IACTA Pharmaceuticals Founder & CEO Damon BurrowsEpisode • Sep 15, 2021

Leading a Young Company with a Five-Generation History with Jean-Frédéric ChibretEpisode • Sep 8, 2021

Intimate Discussions from OIS Israel Innovation ShowcaseEpisode • Sep 1, 2021

Leading a Global Leader, with Pierre BillardonEpisode • Aug 25, 2021

Discovering the Therapeutic Power of Collagen MimeticsEpisode • Aug 11, 2021

Living the Dream with Donald Korb, ODEpisode • Aug 11, 2021

Developing a Clear Vision for a Clinical-Stage Company with Ben BergoEpisode • Aug 4, 2021

Building a Best-in-Class Company for a Best-in-Class Therapy: LENZ Therapeutics CEO Eef SchimmelpenninkEpisode • Jul 28, 2021

Balancing a Passion for Science & Business — Alcon’s Jeannette BankesEpisode • Jul 21, 2021

The 3 T’s - Technique, Technology and Teaching with Steve Charles, MDEpisode • Jul 14, 2021

Paul Ryb, the Ability to Live & Succeed with Sight LossEpisode • Jul 7, 2021

The Architect of Pharmaceuticals with Marc Gleeson, CEO of Azura OphthalmicsEpisode • Jun 30, 2021

Vision is Everything with Samsara’s Tom RuggiaEpisode • Jun 23, 2021

Zeiss Meditec’s Euan Thomson Says Data at Scale Will Enable New Insights in HealthcareEpisode • Jun 16, 2021

Roll Up Your Sleeves with Oyster Point’s John SnisarenkoEpisode • Jun 9, 2021

B+L’s Chuck Hess is Looking to Change the Game in OphthalmologyEpisode • Jun 2, 2021

From Competitive Athlete To Pharma CEOEpisode • May 26, 2021

Fueled by Passion to Advance DevelopmentEpisode • May 19, 2021

Taking Alcon Back to BasicsEpisode • May 12, 2021

Earning the Right to Ask for the Business with Nick Curtis of LENSAREpisode • May 5, 2021

Drug Hunter by Day with Arthur Suckow, PhDEpisode • Apr 28, 2021

Dr. Bala Ambati Discusses The Long Journey from Idea to ImpactEpisode • Apr 21, 2021

Building Value for Pipeline Assets with Mina SoochEpisode • Apr 14, 2021

Paul Karpecki, OD, FAAO, Leads a Panel of Industry Experts in a Discussion on the Dry Eye LandscapeEpisode • Mar 31, 2021

Ashley Brissette, MD Leads Discussion with KOLs on the Complexities and Management of Dry Eye DiseaseEpisode • Mar 24, 2021

Building Trust in BusinessEpisode • Mar 17, 2021

The Reversal of Age-Related Ophthalmic DisordersEpisode • Mar 10, 2021

KOLs Speak Out on the Future of Gene TherapyEpisode • Mar 3, 2021

The Sky’s the Limit with the Venerable Vince AnidoEpisode • Feb 24, 2021

Dr. Cal Roberts’ Latest Leap to LighthouseEpisode • Feb 17, 2021

The Vision of TearClear’s Future with CEO, Robert DempseyEpisode • Feb 10, 2021

Navigating Regulatory Hurdles with Kim Brazzell, PhDEpisode • Feb 3, 2021

Banishing Bureaucracy at BVIEpisode • Jan 27, 2021

Invest in 2021 with the Best in Ophthalmic BusinessEpisode • Jan 20, 2021

Venturing into Ophthalmology with ExSightEpisode • Jan 13, 2021

Outlook’s Plan for Bevacizumab-vikgEpisode • Jan 6, 2021

A Vision for BusinessEpisode • Dec 23, 2020

OIS Industry Panel on Retina Start-upsEpisode • Dec 16, 2020

Investing in the Future of OphthalmologyEpisode • Dec 9, 2020

KOL Perspective on Glaucoma Therapies and DevelopmentEpisode • Dec 2, 2020

Discussion on Drug Delivery Technologies with Some of Pharma’s Best and Brightest ExecutivesEpisode • Nov 25, 2020

Nature as an Inspiration for InnovationEpisode • Nov 18, 2020

A lot of Skill and a Little Bit of LuckEpisode • Nov 11, 2020

The Steve Jobs of OphthalmologyEpisode • Nov 4, 2020

Doctor to Doctor with President and CEO, Euclid Systems CorporationEpisode • Oct 28, 2020

An Intimate Look at the Future of Ocular Gene TherapyEpisode • Oct 21, 2020

A Stimulating Conversation with Patrik De Haes, MD - CEO at OxurionEpisode • Oct 14, 2020

Tim Clover, CEO of Rayner Talks About the Company’s Deep History in Ophthalmology, As Well As Their Future Plans For InnovationEpisode • Oct 7, 2020

Impacting Lives Using Tomorrow's TechnologyEpisode • Sep 30, 2020

A Dynamic Career in RetinaEpisode • Sep 23, 2020

Follow Your PassionEpisode • Sep 16, 2020

The ApprenticeEpisode • Sep 9, 2020

Never Take No For An AnswerEpisode • Sep 2, 2020

Listening to the Needs of the CustomerEpisode • Aug 26, 2020

Treating Challenges as OpportunitiesEpisode • Aug 20, 2020

Au Petit Bonheur La ChanceEpisode • Aug 13, 2020

The Lindstrom Method: Say ‘Yes’ to OpportunitiesEpisode • Aug 6, 2020

Dr. Ken Mandell’s Passion for InnovationEpisode • Jul 30, 2020

Paul Hallen’s View of Retina from the Catbird’s SeatEpisode • Jul 23, 2020

The Time is Nau!Episode • Jul 15, 2020

OIS Israel Panel Dives Into Global Industry Insights and InnovationEpisode • Jul 9, 2020

From West Point to ONL’s C-Suite - David EspositoEpisode • Jul 2, 2020

John Hovanesian, MD, on Business, Life, Trends, IOL Technology, and MoreEpisode • Jun 25, 2020

OIS Retina Podcast: Interview with Serial Inventor Dr. Mark HumayunEpisode • Jun 18, 2020

Introducing the OIS Retina Podcast!Episode • Jun 11, 2020

Bill Link’s Road to Ophthalmology and VCEpisode • Jun 4, 2020

Innovation Starts at Home (Updated)Episode • May 29, 2020

Challenging Conventional Thinking with the Laws of PhysicsEpisode • May 14, 2020

Elad Kedar and Jeff Weinhuff Share the Recipe for Orasis PharmaceuticalsEpisode • May 7, 2020

Leadership - How to Measure & Motivate in a Startup EnvironmentEpisode • Apr 30, 2020

Bobak Azamian CEO of Tarsus Addresses Unmet Needs in BlepharitisEpisode • Apr 23, 2020

Robert Dempsey New CEO of TearClearEpisode • Apr 16, 2020

Industry Insights into InnovationEpisode • Apr 13, 2020

Innovating Around the GlobeEpisode • Apr 6, 2020

Collaborative Care in Cataracts & Ocular Surface DiseaseEpisode • Mar 30, 2020

Innovation Starts at HomeEpisode • Feb 19, 2020

J&J Vision’s Newly Appointed Worldwide President of Surgical, Mr. Warren Foust Meets with OIS PodcastEpisode • Jan 14, 2020

J&J’s Tom Frinzi Provides Updates on Innovation Efforts & MoreEpisode • Sep 4, 2019

Mitro Opens Up About Aerie’s ProgramsEpisode • Jul 10, 2019

Novartis’ Patrick Mooney Gives Inside Look on the Impact of Alcon Spin-Out, Bid to Acquire XiidraEpisode • May 14, 2019

Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future PotentialEpisode • Apr 24, 2019

Oculis CEO Riad Sherif Talks About Novartis, Alcon, and What’s Promising in His Company’s PipelineEpisode • Apr 17, 2019

Oyster Point Pharma CEO Jeffrey Nau Highlights Details of the Company’s Recent B Round, Ponders IPOEpisode • Apr 10, 2019

Novaliq’s Bernhard Günther Reveals Company’s Fateful Start, Promising Future for Dry Eye TreatmentsEpisode • Apr 2, 2019

What Impact Will Gene Therapy Deals Have on Patients? Start-Ups? Jay Duker, MD, Can Speak for Both.Episode • Mar 21, 2019

Wall Street Analyst David Nierengarten of Wedbush Dissects Recent Gene Therapy Shopping SpreeEpisode • Mar 13, 2019

BONUS EPISODE: Direct from OIS@SECO - Industry Leaders Speaking Out on the Optometric ChannelEpisode • Feb 28, 2019

Co-Chair James Thimons Walks Us Through the Highs and Even Highers of the First OIS@SECOEpisode • Feb 27, 2019

Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma PathEpisode • Feb 20, 2019

Ocutrx CEO Michael Freeman Honors a Promise to Develop AR Device That Could Help AMD Patients SeeEpisode • Feb 13, 2019

Paul Karpecki Sees ‘a Lot of Opportunity’ to Grow Treatment of Dry Eye and Other Ocular DiseasesEpisode • Feb 5, 2019

Mark Blumenkranz Previews Upcoming Laser-Based Imaging Workshop, Updates on Big Data, Digital TechEpisode • Jan 31, 2019

Justin Schweitzer, OD, of Vance Thompson Vision Talks Glaucoma, Dry Eye, and Clear Career PathsEpisode • Jan 24, 2019

Dry Eye Coach Hauser Shares Insights on New Treatments, Social Media and Working with IndustryEpisode • Jan 16, 2019

Notal Vision CEO Susan Orr Presents a Clear Future for AMD Patients Conducting OCT Scans at HomeEpisode • Jan 10, 2019

Eric Donnenfeld, MD, Handicaps a Crowded Field in the Race to Develop the Next Dry Eye BlockbusterEpisode • Dec 12, 2018

Chris Wroten, OD, Recalls Indirect Path into Eye Care, Sees Enormous Need for Upcoming OIS@SECOEpisode • Dec 5, 2018

Silverstein Traces His Path to Ophthalmology, Interest in Local Affairs, and Reliance of LIVEpisode • Nov 28, 2018

In our 200th Episode, IDx Founder Shares Wisdom from Recent Success with the FDA, Venture InvestorsEpisode • Nov 14, 2018

Web Vision Technologies CEO Bob Main Explains Why He’s Looking for The Right Stuff to Aid AstronautsEpisode • Nov 8, 2018

With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?Episode • Nov 1, 2018

Can Swiss Start-Up Ophthorobotics Develop a Robotics System to Deliver Intravitreal Injections?Episode • Oct 31, 2018

Eyedaptic CEO Jay Cormier Lays Out Start-Up’s Vision for Augmented Reality Visual Restoration DeviceEpisode • Oct 3, 2018

Simple Contacts CEO Joel Wishkovsky Says Start-Up’s App Could Upend Vision CareEpisode • Sep 26, 2018

James Thimons, OD, Discusses Technology’s Positive Impact on Diagnosing and Treating Eye DiseaseEpisode • Sep 20, 2018

Glaukos COO Calcaterra Lays out Pipeline Plans Following iStent inject OK, Reacts to CyPass RecallEpisode • Sep 13, 2018

Louis Pasquale Discusses Eyenovia’s Trial, Other Causes of Glaucoma, and the Promise of TelemedicineEpisode • Aug 24, 2018

Peter Menziuso, JJV President, North America Vision Care, Lobbying for Protections in the Contact Lens RuleEpisode • Aug 22, 2018

REGENXBIO CEO Ken Mills Shines Light on Promising Phase I Trials for Wet AMD Gene Therapy RGX-314Episode • Aug 15, 2018

Doug Foster, Chief Strategy Officer of Verana Health, Explains Plans to Replicate IRIS PartnershipEpisode • Aug 8, 2018

Did You Miss OIS Retina (or Just Miss Being in Vancouver?) Hear Highlights from the Meeting FloorEpisode • Aug 2, 2018

Skimming the Ocular Surface with TFOS’ Amy Gallant Sullivan and Purdue Researcher Chi Hwan LeeEpisode • Jul 18, 2018

Oyster Point Pharma CEO Nau Takes a Deeper Dive into Just-Released PEARL Trial ResultsEpisode • Jul 12, 2018

John Berdahl Speaks on the Importance of Mentors and Changing Views on How to Treat GlaucomaEpisode • Jun 27, 2018

Surgeon/Engineer Steve Charles Has Advice for Aspiring Inventors: Never Stop Learning; Dump NetflixEpisode • Jun 13, 2018

CEO Sean Ianchulev Shares Eyenovia's Plans to Replace Eye Drops with New Microdosing TechnologyEpisode • May 31, 2018

OIS Podcast Update on Dry Eye and MGD - What's Up at J&J, Oyster Point and Tear Film Innovations?Episode • May 23, 2018

OIS Podcast Finds Out What's Next for Nicox and Zeiss in Two Talks with Michele Garufi and Jim MazzoEpisode • May 16, 2018

OIS Podcast Talks Fund-raising with Avedro's Reza Zadno, Innovation with Allergan's Bill MeuryEpisode • May 10, 2018

Dry Eye Coach Hauser Speaks to How New Tech - Including Social Media - Can Bolster a PracticeEpisode • Apr 4, 2018

AcuFocus President Al Waterhouse Explains Company's Decision to Sell Kamra Inlay to Focus on IOLsEpisode • Mar 29, 2018

SightLife Surgical CEO Monty Montoya Says Start-Up Is Building Out Cornea MarketEpisode • Mar 22, 2018

CEO David Muller Says Allotex Looks to Create Living Contact Lens with Corneal AllograftEpisode • Mar 14, 2018

AGTC's Washer on What it Means to Join BIO BoardEpisode • Feb 28, 2018

Shire's Dempsey Highlights Global Leader's Early Bet in Optometry, Role in Upcoming OIS LaunchEpisode • Feb 23, 2018

Hear Details on Feb. 28 Dry Eye Dinner at SECO, Interview with J&J's Dry Eye Head, Joe BooradyEpisode • Feb 14, 2018

New CEO Mattessich Brings in New Skills, Leadership to Help Ocular Therapeutix Reach PotentialEpisode • Feb 7, 2018

Pixium Vision CEO Sees a Day When Wireless PRIMA Implant Could Bring Vision Back to AMD PatientsEpisode • Jan 31, 2018

We Ask Analysts How Will Pharma and Medtech Companies Spend Billions in Repatriated OUS Profits?Episode • Jan 25, 2018

Life After the IPO: What Does Apellis Have Planned After Raising $170m from Public Investors?Episode • Jan 17, 2018

Drug Pricing Pro Roger Longman of Real Endpoints Says Spark Therapeutics Is Making the Right MovesEpisode • Jan 10, 2018

Oyster Point Pharma CEO Jeff Nau Taps Experience, Successful Network to Build Dry Eye Start-upEpisode • Jan 4, 2018

Using AI to Improve Diagnosis of DiseaseEpisode • Dec 13, 2017

Part II: OIS Co-chair Emmett Cunningham, Jr. Delivers Annual Overview on the State of OphthalmologyEpisode • Dec 6, 2017

OIS Co-chair Emmett Cunningham, Jr., MD. Delivers Annual Overview on the State of OphthalmologyEpisode • Nov 29, 2017

Dry Eye Diaries: Hear Tales and Hopes from Leaders of Shire, Johnson & Johnson, and TearSolutionsEpisode • Nov 21, 2017

CEO Brent Saunders Lays out Allergan’s Plans for Ophthalmology, Restasis, and InnovationEpisode • Nov 15, 2017

Donnenfeld, MD, Talks Blue Sea PE Deal, OD/MD Collaboration, and Why OCLI Got CheckedUpEpisode • Nov 7, 2017

OIS Co-Chair Emmett Cunningham Walks through the Upcoming OIS@AAO Agenda, Reveals New Ways to EngageEpisode • Nov 1, 2017

Aerie CEO Anido Talks War Rooms, FDA, Rhopressa, Roclatan, and Getting Along with the NeighborsEpisode • Oct 25, 2017

Gemini CEO McLaughlin Explains How the Precision Therapeutics Start-up Will Take Aim at Eye DiseaseEpisode • Oct 18, 2017

What’s Next PanOptica? We Ask CEO ChaneyEpisode • Oct 11, 2017

ExSight Capital, Partner Firas Rahhal, MD, Are Building a Successful Record as Impact InvestorEpisode • Oct 4, 2017

Dr. Pravin Dugel Picks Possible Winners in Race to Deliver New Retinal TreatmentsEpisode • Sep 28, 2017

Hatteras’ Shaffer Found a Model That Works at Inspire; Now She Uses It When Making InvestmentsEpisode • Sep 20, 2017

Digital Health Is Dead? Don’t Tell Mark Blumenkranz, the FDA, or the Organizers of an Oct. WorkshopEpisode • Sep 13, 2017

What Was the Most Difficult Part of Successfully Transitioning to CMO? We Ask B&L’s Cal RobertsEpisode • Sep 6, 2017

Imperial College’s Dr. Cordeiro Explains How DARC May Bring Early Light to Disease, Shorten TrialsEpisode • Aug 28, 2017

Why Did Charles Semba, MD, Switch Specialties and How Did He Find a Home in Ophthalmology?Episode • Aug 23, 2017

OIS@ASRS Co-Chairs Give High Marks and Hopes for Innovators Looking at the Back of the EyeEpisode • Aug 16, 2017

What Does TearScience Deal Mean for J&J? Group Chair Ashley McEvoy Shines Light on Future PlansEpisode • Aug 8, 2017

Should You Be at OIS@ASRS on Thursday? Take an Insider Look at the Agenda with Emmett CunninghamEpisode • Aug 8, 2017

Allegro’s Poised to Deliver Positive News at ASRS; Could an IPO Be Next? We Ask Vicken KarageozianEpisode • Aug 2, 2017

Double Shot: Two Leading Ophthalmologists Discuss the Impact Innovation Is Having on Eye CareEpisode • Jul 26, 2017

Investor, Executive Shine Light on Private Equity’s Growing Interest and Influence in OphthalmologyEpisode • Jul 18, 2017

Sun Pharma’s St. Peter Outlines Company’s Ambitious Plan to Build Ophthalmology PipelineEpisode • Jul 11, 2017

Alcon's Attias Touts Growing Pipeline Including Progress in Glaucoma and Google ProjectsEpisode • Jul 5, 2017

NEA's Behbahani, with New Fund to Invest, Discusses VC's Strong Interest in OphthalmologyEpisode • Jun 27, 2017

Implandata Co-Founder Outlines Next Step as Company Scores CE Mark for Continuous IOP Monitoring DeviceEpisode • Jun 21, 2017

Mynosys CEO Hendrick Lays Out Next Step for Zepto Following Positive FDA, Strong OUS LaunchEpisode • Jun 14, 2017

Donnenfeld Discusses How New Diagnostics, Treatments Impact His Practice and PatientsEpisode • Jun 7, 2017

COO Tom Mitro Discusses Aerie’s Preparation for Rhopressa Launch, Updates OIS@ASCRS on PipelineEpisode • May 31, 2017

CEO Ludwin Monz Discusses Zeiss’ Important Management Hires, SMILE, and the Future of DiagnosticsEpisode • May 24, 2017

Alice Epitropoulos, MD, on How Xiidra, TrueTear, and Other Treatments Impact Practices, PatientsEpisode • May 18, 2017

CEO Ram Rao Discusses Juvene, the Rise of Presbyopia, and How LensGen Raised $21 millionEpisode • May 10, 2017

In an Insightful Wrap-up, OIS Co-chairs Share the Top Takeaways from another Successful OIS@ASCRSEpisode • May 7, 2017

Can OIS Help Make Myopia Great Again? Co-chair Kliman Discusses Inventive New Panel, OpportunitiesEpisode • Apr 27, 2017

Award Winner Korroch Explains How Eye Banks Have Worked to Ensure Supply Exceeds DemandEpisode • Apr 20, 2017

What’s the Difference between Creativity and Innovation? Blumenkranz Answers That and Much MoreEpisode • Apr 12, 2017

OIS Co-Chair Bill Link Walks Us Through OIS@ASCRS May 4 Agenda and Introduces Flying L PartnersEpisode • Apr 5, 2017

Prolific Investigator Thompson Gives His Take on SMILE, Cross-Linking, Oculeve, and Other InnovationsEpisode • Mar 29, 2017

Co-author Thomas Albini, MD, Explains Why Eye Docs Wrote NEJM Paper to Expose Stem Cell InjuriesEpisode • Mar 22, 2017

Nancy Lurker Discusses Bringing Her Commercial Experience, Insights to Drug Delivery Upstart pSividaEpisode • Mar 15, 2017

We Ask Dick Lindstrom What Practice Consolidation May Mean for Ophthalmology, Innovation (Pt. 2)Episode • Mar 8, 2017

Dick Lindstrom Tells us why Minnesota Eye Consultants Partnered With a Private Equity Firm (Pt. 1)Episode • Mar 1, 2017

Apellis CEO Delivers Some Hopeful Pipeline News, and Offers a Cautionary Note on Immigration DebateEpisode • Feb 23, 2017

Eyes Up! NEI Challenges “Solvers” to Create 3D Retina Organoid that Could Aid ResearchEpisode • Feb 15, 2017

Abbie Celniker Shares Her View of Pharma, Ophthalmology from High-flying Third Rock VenturesEpisode • Feb 9, 2017

Can Presbyopia Therapies Deliver an Encore with its Own Vision-Correcting Eye Drops?Episode • Feb 2, 2017

Novartis Sees Clear Opportunity in Encore Vision’s Unique Approach to Correcting PresbyopiaEpisode • Jan 27, 2017

Looking Beyond the Tweets: What Trump’s Pharma Pricing Pledge Might Mean for OphthalmologyEpisode • Jan 18, 2017

Novaliq’s Positive Phase II Dry Eye Results Present Break from Disappointing Clinical Trial SeasonEpisode • Jan 12, 2017

EyeGate Pharma Discusses Early Clinical Trials Success, Promising Pipeline, and Partnership PayoutsEpisode • Jan 6, 2017

What Now? What Does Ophthotech’s Disappointing Phase III Results Mean for Wet AMD, VEGF and PDGF?Episode • Dec 16, 2016

Can Lighting Strike Twice? SARCode’s Co-Founder Gadek Takes Helm of Promising Dry Eye Start-upEpisode • Dec 7, 2016

Andrew Chang Discusses His Move to Lead Global Sales of Zeiss Meditec’s Ophthalmic DevicesEpisode • Nov 30, 2016

What Are Tom Frinzi’s Plans after J&J Acquires AMO? Frinzi Talks J&J, Symfony, and Much MoreEpisode • Nov 22, 2016

OIS Editorial Roundtable: What Impact Will a Trump Administration Have on Ophthalmology?Episode • Nov 16, 2016

Carl Zeiss’s Jim Mazzo Talks About Failing Fast, the Reply All Button and Reaching the CustomerEpisode • Nov 9, 2016

How it All Began. Allergan’s Herbert Shares Details of His Contribution to Ophthalmology’s OriginsEpisode • Nov 1, 2016

David Pyott on Growing Allergan, Defending Against Acquisitions, and How the Next Chapter Will ReadEpisode • Oct 27, 2016

Live (sort of) from Chicago: OIS Podcast Brings You the Voices of OIS@AAOEpisode • Oct 20, 2016

Introducing Our Newest Tool – the OIS IndexEpisode • Oct 12, 2016

OIS Founder & Co-Chair Emmett Cunningham Jr. Tells Us What to Watch for Next Week in ChicagoEpisode • Oct 5, 2016

Hear How Preceyes Will Help Usher Robotics into Ophthalmic SurgeryEpisode • Sep 28, 2016

Behind the Deal: McEvoy On Where Will AMO Fit into J&J & What the Deal Means for Eye CareEpisode • Sep 21, 2016

Live (sort of) from Copenhagen: OIS Podcast Hits the High Points of ESCRS and EuRetinaEpisode • Sep 15, 2016

Xiidra Prior to Shire: How SARcode Took on the Odds to Pursue a New Treatment for Dry EyeEpisode • Sep 8, 2016

A note from OIS PodcastEpisode • Sep 1, 2016

100th Episode & CountingEpisode • Aug 25, 2016

CEO John Kilcoyne Reviews ReVision’s Success with the FDA & its Plans to Roll Out RaindropEpisode • Aug 18, 2016

Live from the Floor of OIS@ASRS: Co-Chair Bill Link on What Made the Day Work So WellEpisode • Aug 11, 2016

What Will Carl Zeiss Meditec’s New Ophthalmology Unit Look Like? We Ask Jim Mazzo.Episode • Aug 3, 2016

Clearside Biomedical Finds the Public Markets Despite Diminished Interest in SectorEpisode • Jul 26, 2016

Can Allegro’s Integrin Peptide Therapy Help Usher in Retina 2.0 for Vitreoretinal Indications?Episode • Jul 20, 2016

Godspeed Xiidra. Shire’s Robert Dempsey Introduces the Newest FDA-Approved Treatment for Dry Eye.Episode • Jul 12, 2016

What Drives Innovators? Pioneer Mark Humayun, MD, PhD, Shares His Story & Vision for OphthalmologyEpisode • Jul 6, 2016

A Walk Down Wall Street: Two Analysts Tell You What to Expect From the Markets in the Coming MonthsEpisode • Jun 29, 2016

Steven Vold, MD, Sees Enormous Potential in Coming Tide of IOLs, Diagnostics & Potential New DrugsEpisode • Jun 22, 2016

Aldeyra CEO Highlights Clinical Trial Success of Possible Treatments for Conjunctivitis, UveitisEpisode • Jun 15, 2016

Ludwin Monz, PhD, Discusses Zeiss, its Legacy & Where it Pursues New InnovationEpisode • Jun 8, 2016

Bausch & Lomb’s CMO Cal Roberts on How He Uses His MD & Experience to Build the Right Tool Kit for OphthalmologistsEpisode • May 31, 2016

Dempsey on Building the Shire Brand in OphthalmologyEpisode • May 24, 2016

OISPodcast@ASCRS - Meury: Why Allergan Won’t Miss a Beat in Building Ophthalmology FranchiseEpisode • May 19, 2016

What the Heck Happened at OIS@ASCRS?Episode • May 15, 2016

Graybug Vision – Flush with Cash – Is Making Big Moves to Change its Approach to Finding New Treatments for Wet AMD & Other Eye DiseaseEpisode • May 3, 2016

Sun Ophthalmics Looks to Build a Brand-New Business in the USEpisode • Apr 28, 2016

Avedro’s Long Wait for FDA Approval is OverEpisode • Apr 20, 2016

What are Allergan’s Next Steps?Episode • Apr 13, 2016

KOL Corner: Can Complement Inhibitors Treat Macular Degeneration?Episode • Apr 6, 2016

Frinzi shares a bit of his plans for AMOEpisode • Mar 29, 2016

Can Apellis Find a Way to Inhibit the Complement System & Treat Intermediate AMD?Episode • Mar 24, 2016

Lewis Handicaps MIGS Market and Explains Glaucoma’s EmergenceEpisode • Mar 16, 2016

VisionCare Battling Back against Macular DegenerationEpisode • Mar 9, 2016

Heier Talks Anti-Angiopoietin Programs, Clinical Trials & Red SoxEpisode • Mar 2, 2016

KOL Corner: Alcon, Transcend & Glaucoma 360Episode • Feb 25, 2016

KOL Corner: Alcon, Transcend & Glaucoma 360Episode • Feb 25, 2016

What Does the Leadership Shuffle Mean for Ophthalmology?Episode • Feb 18, 2016

EyeGate Finds New Paths to Dollars, DealEpisode • Feb 11, 2016

Muller Explains Departure from Avedro; Opportunity in New VentureEpisode • Feb 3, 2016

Inotek’s Southwell and McVicar Have Designs on Treating GlaucomaEpisode • Dec 16, 2015

Emptying the OIS Reporter’s Notebook After OIS@AAOEpisode • Dec 9, 2015

Where Will `Pfizergan’ Fit in OphthalmologyEpisode • Dec 1, 2015

Aura Biosciences Offers Hope for Ocular MelanomaEpisode • Nov 23, 2015

A Rundown of a Record-setting OISEpisode • Nov 19, 2015

Celniker Gets Eleven Bio Ready For OIS and Conference SeasonEpisode • Nov 9, 2015

Ora’s Ousler Delves Deep into Dry EyeEpisode • Nov 2, 2015

Muller on the FDA, PIXL and Dairy FarmsEpisode • Oct 28, 2015

Biogen’s High Hopes For Gene Therapy, OphthalmologyEpisode • Oct 21, 2015

Understanding Market Cycles: When Could Biotech UnBoom?Episode • Oct 13, 2015

Can Spark Phase III Results Ignite Gene Therapy?Episode • Oct 8, 2015

Implandata's Hands-On Approach To Tracking IOPEpisode • Sep 30, 2015

Sadri: How MIGS And Other New Tech May Change His PracticeEpisode • Sep 23, 2015

OcuSciences Hopes to Give Early Warning on Ocular DiseaseEpisode • Sep 16, 2015

Imprimis’ Baum on Disrupting Compound PharmaciesEpisode • Sep 9, 2015

Opthea Exploring Different Approach To Treating Wet AMDEpisode • Aug 31, 2015

Makower: Making Medtech Bigger, Stronger, FasterEpisode • Aug 26, 2015

ClarVista’s Two-Part Strategy To Premium IOLsEpisode • Aug 19, 2015

CEO Tom Burns Has Even Bigger Plans For GlaukosEpisode • Aug 12, 2015

Year 1: What OIS Podcasts Were Most Popular? Part TwoEpisode • Aug 5, 2015

Year 1: What OIS Podcasts Were Most Popular?Episode • Jul 29, 2015

A Favorite From The OIS Podcast StackEpisode • Jul 21, 2015

Clarus Delivers Good News With $500m FundEpisode • Jul 14, 2015

Oculeve Open Ups, Just a Little, on OD-01Episode • Jul 8, 2015

Hear Bausch & Lomb’s Ophthalmology Play BookEpisode • Jun 30, 2015

A discussion of Allergan’s legacy and future in Medtech OphthalmologyEpisode • Jun 23, 2015

Here is How Big Companies InnovateEpisode • Jun 15, 2015

Hear How Valeant Innovates, Invests and AcquiresEpisode • Jun 10, 2015

Transcend Medical Ready To Make Move In MIGsEpisode • Jun 2, 2015

Borrmann Gives View Into AMO’s Innovation CycleEpisode • May 26, 2015

OIS Optical Overview: Haimovich, Lachman Share Insights On OIS, MIGs, IOLs, etc.Episode • May 19, 2015

Avedro CEO Muller Answers Questions about the FDA’s QuestionsEpisode • May 12, 2015

Lindstrom Wins Ophthalmology Innovator AwardEpisode • May 4, 2015

Mazzo Details Plans For Kamra Inlay’s Introduction To The US Following FDA ApprovalEpisode • Apr 27, 2015

Alternative Financing ApproachesEpisode • Apr 21, 2015

PowerVision’s Cheskin discusses the potential of the company’s accommodating IOL, FluidVisionEpisode • Apr 13, 2015

Alphaeon’s Grant Explains Innovative New ModelEpisode • Apr 7, 2015

Co-Chair Link Gives Overview of Upcoming OISEpisode • Mar 31, 2015

Alcon’s Attias Offers Insights on InnovationEpisode • Mar 24, 2015

Holland Delivers Overview of ASCRS, OphthalmologyEpisode • Mar 16, 2015

Talley Rostov Works to Improve Global VisionEpisode • Mar 10, 2015

Blumenkranz Shares His Success, Failures And New Opportunities For Ophthalmic InnovatorsEpisode • Mar 2, 2015

Alcon’s Plan For WaveTec’s ORA SystemEpisode • Feb 24, 2015

CEO Russ Trenary Discusses InnFocus’ Push into the Competitive MIGs MarketEpisode • Feb 17, 2015

Ophthalmology By The Numbers With Jon Norris of SVBEpisode • Feb 9, 2015

DigiSight Puts Eye Care in Patients’ HandsEpisode • Feb 3, 2015

Vance Thompson, MD, Speaks to Importance of Patient “Experience” in a successful practice.Episode • Jan 27, 2015

A multi-generational look at ophthalmology with Dr. George O. Waring IVEpisode • Jan 20, 2015

Second Sight Fulfills DreamEpisode • Jan 13, 2015

Eleven’s Celniker Talks Leadership, Public Markets, and Phase III Dry Eye TrialsEpisode • Jan 6, 2015

Cunningham: 2015 Could Be A Big Year For OphthalmologyEpisode • Dec 16, 2014

TearScience CEO Willis Explains Dry Eye Disease’s EmergenceEpisode • Dec 9, 2014

Alimera CEO Myers Shares Lessons From Iluvien FDA ApprovalEpisode • Dec 2, 2014

Opening The Door For Premium IOLsEpisode • Nov 24, 2014

Ocular Therapeutix Starting to SprintEpisode • Nov 17, 2014

Alcon Head Jeff George Lays Out VisionEpisode • Nov 11, 2014

How Thoughtful Consolidation Can Benefit OphthalmologyEpisode • Nov 3, 2014

How Alcon and Google Could Change the Contact LensEpisode • Oct 28, 2014

NASA-Backed Entity Enlists Industry To Battle Eye Disorders Caused By Space TravelEpisode • Oct 21, 2014

Dirk Sauer Oversees Novartis’ Promising And Productive Ophthalmic PipelineEpisode • Oct 13, 2014

Gobiquity Goes Big In Mobile Imaging DiagnosticsEpisode • Oct 7, 2014

Anido Guides Aerie’s Push To Be A “Very Big Player” In GlaucomaEpisode • Sep 29, 2014

Slade Discusses the Opportunities, and Challenges, of New Technology.Episode • Sep 22, 2014

Hear How Avedro’s Muller Is Building A Cross-Linking PowerhouseEpisode • Sep 15, 2014

Ophthalmology Is A “Leading Franchise” At InterWestEpisode • Sep 9, 2014

Lindstrom: Ophthalmologists Facing Both Opportunity And PressureEpisode • Sep 2, 2014

Cunningham: Strong Signs Ahead For Ophthalmology InnovationEpisode • Aug 25, 2014

Donnenfeld Bullish on Ophthalmic InnovationEpisode • Aug 18, 2014

Link Says Versant's Eyes Will Be on OphthalmologyEpisode • Aug 12, 2014

Mazzo Muses on the FDA, Google and Failing FastEpisode • Aug 4, 2014

Latest activity

Switch to the Fountain App

Open in Fountain